SCOPUS 정보 검색 플랫폼

Molecular Genetics, Microbiology and Virology

Volumn 27, Issue 1, 2012, Pages 7-15

Oncolytic poxviruses

(6) Kochneva, G V a,b Sivolobova, G F a,b Yudina, K V a,b Babkin, I V c Chumakov, P M a,d,e Netesov, S V a

a NOVOSIBIRSK STATE UNIVERSITY (Russian Federation)

b STATE RESEARCH CENTER OF VIROLOGY AND BIOTECHNOLOGY VECTOR (Russian Federation)

c INSTITUTE OF CHEMICAL BIOLOGY AND FUNDAMENTAL MEDICINE (Russian Federation)

d ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY (Russian Federation)

e LERNER RESEARCH INSTITUTE (United States)

Author keywords

angiogenesis inhibitors; interleukins; p53 protein; thymidine kinase; Vaccinia; viral recombinant

Indexed keywords

BETA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 2; ONCOLYTIC VIRUS; THYMIDINE KINASE; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; VASCULOTROPIN; VIRUS DNA;

ANTINEOPLASTIC ACTIVITY; BIOLUMINESCENCE; CELL DIVISION; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; CYTOTOXICITY; ENDOCYTOSIS; EXTRACELLULAR MATRIX; GENE DELETION; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE INSERTION; GENE REPRESSION; GENETIC CONSERVATION; GLIOBLASTOMA; GLIOMA; GOLGI COMPLEX; GRANULOCYTE; HUMAN; IMMUNOMODULATION; LEPORIPOXVIRUS; LIVER CELL CARCINOMA; MACROPHAGE; MOLLUSCIPOXVIRUS; MYXOMA VIRUS; NONHUMAN; NUCLEOSOME; ONCOLYTIC VIROTHERAPY; ORTHOPOXVIRUS; OVARY CANCER; PARAPOXVIRUS; POXVIRUS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN STRUCTURE; REVIEW; TK GENE; TRANSGENE; VACCINIA VIRUS; VGF GENE; VIRAL GENETICS; VIRION; VIRUS ATTENUATION; VIRUS ENVELOPE; VIRUS GENE; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TITRATION;

POXVIRIDAE; VACCINIA VIRUS;

EID: 84860246491 PISSN: 08914168 EISSN: 1934841X Source Type: Journal
DOI: 10.3103/S0891416812010041 Document Type: Review

Times cited : (15)

References (76)

1
- 0031759989
- 9930346 1:CAS:528:DyaK1cXms1Wmtb4%3D 10.1038/sj.gt.3300731
- C. Addison J. Bramson M. Hitt, et al. 1998 Gene Ther. 5 1400 1409 9930346 1:CAS:528:DyaK1cXms1Wmtb4%3D 10.1038/sj.gt.3300731
- (1998) Gene Ther. , vol.5 , pp. 1400-1409
- Addison, C.¹ Bramson, J.² Hitt, M.³

2
- 0032191176
- Role of early cytokines, including alpha and beta interferons (IFN-α/β), in innate and adaptive immune responses to viral infections
- DOI 10.1006/smim.1998.0138
- C. Biron 1998 Semin. Immunol. 10 383 390 9799713 1:CAS:528: DyaK1cXnsVekt7g%3D 10.1006/smim.1998.0138 (Pubitemid 28499552)
- (1998) Seminars in Immunology , vol.10 , Issue.5 , pp. 383-390
- Biron, C.A.¹

3
- 67650889118
- 19528476 1:CAS:528:DC%2BD1MXos1Wms7k%3D
- L. Braidwood P. Dunn S. Hardy, et al. 2009 Anticancer Res. 29 2159 2166 19528476 1:CAS:528:DC%2BD1MXos1Wms7k%3D
- (2009) Anticancer Res. , vol.29 , pp. 2159-2166
- Braidwood, L.¹ Dunn, P.² Hardy, S.³

4
- 77953543075
- 20472490 1:CAS:528:DC%2BC3cXmslGitrc%3D 10.1016/j.cytogfr.2010.02.001
- C. Breitbach T. Reid J. Burke, et al. 2010 Cytokine Growth Factor Rev. 21 85 89 20472490 1:CAS:528:DC%2BC3cXmslGitrc%3D 10.1016/j.cytogfr.2010.02.001
- (2010) Cytokine Growth Factor Rev. , vol.21 , pp. 85-89
- Breitbach, C.¹ Reid, T.² Burke, J.³

5
- 0036377745
- + T helper cell-independent antitumor response mediated by murine IFN-β gene delivery in immunocompetent mice
- DOI 10.1089/10799900260100222
- J. Brown J. Barsoum X. Qin 2002 J. Interferon Cytokine Res. 22 719 728 12162884 1:CAS:528:DC%2BD38Xlt1Kltbw%3D 10.1089/10799900260100222 (Pubitemid 35034532)
- (2002) Journal of Interferon and Cytokine Research , vol.22 , Issue.6 , pp. 719-728
- Brown, J.L.¹ Barsoum, J.² Qin, X.-Q.³

6
- 0023837303
- 3339716 1:CAS:528:DyaL1cXht1Gnu7o%3D
- R. Buller S. Chakrabarti J. Cooper, et al. 1988 J. Virol. 62 866 874 3339716 1:CAS:528:DyaL1cXht1Gnu7o%3D
- (1988) J. Virol. , vol.62 , pp. 866-874
- Buller, R.¹ Chakrabarti, S.² Cooper, J.³

7
- 0030862430
- 9421642 1:CAS:528:DyaK2sXnvFCqsLs%3D
- S. Chakrabarti J. Sisler B. Mass 1997 BioTechniques 23 1094 1097 9421642 1:CAS:528:DyaK2sXnvFCqsLs%3D
- (1997) BioTechniques , vol.23 , pp. 1094-1097
- Chakrabarti, S.¹ Sisler, J.² Mass, B.³

8
- 38349079989
- 10.1038/sj.cgt.7701110
- S. Chalikonda M.H. Kivlen M. O'Mallkey, et al. 2008 Cancer Gene Ther. 15 5 25 10.1038/sj.cgt.7701110
- (2008) Cancer Gene Ther. , vol.15 , pp. 5-25
- Chalikonda, S.¹ Kivlen, M.H.² O'Mallkey, M.³

9
- 0033669314
- 11129286 1:CAS:528:DC%2BD3cXoslWru7c%3D 10.1038/sj.cgt.7700252
- B. Chen T. Timiryasova M. Andres, et al. 2000 Cancer Gene Ther. 7 1437 1447 11129286 1:CAS:528:DC%2BD3cXoslWru7c%3D 10.1038/sj.cgt.7700252
- (2000) Cancer Gene Ther. , vol.7 , pp. 1437-1447
- Chen, B.¹ Timiryasova, T.² Andres, M.³

10
- 0035139013
- Low-dose vaccinia virus-mediated cytokine gene therapy of glioma
- DOI 10.1097/00002371-200101000-00006
- B. Chen T. Timiryasova P. Haghighat, et al. 2001 J. Immunother. 24 46 57 11211148 1:CAS:528:DC%2BD3MXps1ajsw%3D%3D 10.1097/00002371-200101000-00006 (Pubitemid 32101967)
- (2001) Journal of Immunotherapy , vol.24 , Issue.1 , pp. 46-57
- Chen, B.¹ Timiryasova, T.M.² Haghighat, P.³ Andres, M.L.⁴ Kajioka, E.H.⁵ Dutta-Roy, R.⁶ Gridley, D.S.⁷ Fodor, I.⁸

11
- 0031906150
- 9445060 1:CAS:528:DyaK1cXlt1Ogug%3D%3D
- C. Chung J. Hsiao Y. Chang W. Chang 1998 J. Virol. 72 1577 1585 9445060 1:CAS:528:DyaK1cXlt1Ogug%3D%3D
- (1998) J. Virol. , vol.72 , pp. 1577-1585
- Chung, C.¹ Hsiao, J.² Chang, Y.³ Chang, W.⁴

12
- 0026442689
- 1431106 1:CAS:528:DyaK3sXnvFSgtQ%3D%3D
- G. Cox G. Melillo U. Chaltopadhyay, et al. 1992 J. Immunol. 149 3290 3296 1431106 1:CAS:528:DyaK3sXnvFSgtQ%3D%3D
- (1992) J. Immunol. , vol.149 , pp. 3290-3296
- Cox, G.¹ Melillo, G.² Chaltopadhyay, U.³

13
- 0033557916
- 10029078 1:CAS:528:DyaK1MXht1Sisbs%3D
- Z. Dong G. Greene C. Pettaway, et al. 1999 Cancer Res. 59 872 887 10029078 1:CAS:528:DyaK1MXht1Sisbs%3D
- (1999) Cancer Res. , vol.59 , pp. 872-887
- Dong, Z.¹ Greene, G.² Pettaway, C.³

14
- 84860229602
- US Patent No. 7563448
- Ellenhorn, I.; Hoshua, D.; and Diamond, Don J.; Modified Vaccinia Ankara Expressing p53 in Cancer Immunotherapy, US Patent No. 7563448, 2009.
- (2009) Modified Vaccinia Ankara Expressing p53 in Cancer Immunotherapy
- Ellenhorn, I.¹ Hoshua, D.² Diamond Don, J.³

15
- 0003974187
- WHO Geneva
- Fenner, F.; Henderson, D.; Arita, I.; et al.; Smallpox and Its Eradication, Geneva: WHO, 1988.
- (1988) Smallpox and Its Eradication
- Fenner, F.¹ Henderson, D.² Arita, I.³

16
- 0032931914
- 9886439 1:CAS:528:DyaK1MXjtlamsQ%3D%3D
- N. Fernandez J. Levraud H. Haddada, et al. 1999 J. Immunol. 162 609 617 9886439 1:CAS:528:DyaK1MXjtlamsQ%3D%3D
- (1999) J. Immunol. , vol.162 , pp. 609-617
- Fernandez, N.¹ Levraud, J.² Haddada, H.³

17
- 78650627880
- 20974979 1:CAS:528:DC%2BC3cXhsVGlt7bJ 10.1073/pnas.1007615107
- M. Fischer M. Allen W. Wilson C. Suttle 2010 Proc. Natl. Acad. Sci. USA 107 45 19508 19513 20974979 1:CAS:528:DC%2BC3cXhsVGlt7bJ 10.1073/pnas.1007615107
- (2010) Proc. Natl. Acad. Sci. USA , vol.107 , Issue.45 , pp. 19508-19513
- Fischer, M.¹ Allen, M.² Wilson, W.³ Suttle, C.⁴

18
- 12544251899
- 1:CAS:528:DC%2BD2MXitl2qtw%3D%3D
- I. Fodor T. Timiryasova B. Denesa, et al. 2005 J. Urol. (Baltimore) 173 604 609 1:CAS:528:DC%2BD2MXitl2qtw%3D%3D
- (2005) J. Urol. (Baltimore) , vol.173 , pp. 604-609
- Fodor, I.¹ Timiryasova, T.² Denesa, B.³

19
- 58349108062
- 18818710 1:CAS:528:DC%2BD1MXkvVKgtQ%3D%3D 10.1038/cgt.2008.67
- K. Fukuda M. Abei H. Ugai, et al. 2009 Cancer Gene Ther. 16 126 136 18818710 1:CAS:528:DC%2BD1MXkvVKgtQ%3D%3D 10.1038/cgt.2008.67
- (2009) Cancer Gene Ther. , vol.16 , pp. 126-136
- Fukuda, K.¹ Abei, M.² Ugai, H.³

20
- 33747128652
- Hypoxia and angiogenesis in pancreatic cancer
- DOI 10.1111/j.1445-2197.2006.03872.x
- G. Garcea H. Doucas W. Steward, et al. 2006 Austr. N. Z. J. Surg. 76 830 842 10.1111/j.1445-2197.2006.03872.x (Pubitemid 44222321)
- (2006) ANZ Journal of Surgery , vol.76 , Issue.9 , pp. 830-842
- Garcea, G.¹ Doucas, H.² Steward, W.P.³ Dennison, A.R.⁴ Berry, D.P.⁵

21
- 0025183685
- The complete DNA sequence of vaccinia virus
- DOI 10.1016/0042-6822(90)90294-2
- S. Goebel G. Johnson M. Perkus, et al. 1990 Virology 179 247 266 2219722 1:CAS:528:DyaK3MXhtFKjuro%3D 10.1016/0042-6822(90)90294-2 (Pubitemid 20354336)
- (1990) Virology , vol.179 , Issue.1 , pp. 247-266
- Goebel, S.J.¹ Johnson, G.P.² Perkus, M.E.³ Davis, S.W.⁴ Winslow, J.P.⁵ Paoletti, E.⁶

22
- 0035123128
- Gene directed enzyme/prodrug therapy of cancer: Historical appraisal and future prospectives
- DOI 10.1002/1097-4652(2001)9999:9999<::AID-JCP1060>3.0.CO;2-H
- O. Greco G. Dachs 2001 J. Cell Physiol. 187 22 36 11241346 1:CAS:528:DC%2BD3MXhs1Kqtb8%3D 10.1002/1097-4652(2001)9999:9999<::AID- JCP1060>3.0.CO;2-H (Pubitemid 32195242)
- (2001) Journal of Cellular Physiology , vol.187 , Issue.1 , pp. 22-36
- Greco, O.¹ Dachs, G.U.²

23
- 1642421758
- Poxvirus genomes: A phylogenetic analysis
- DOI 10.1099/vir.0.19565-0
- C. Gubser S. Hue P. Kellam G. Smith 2004 J. Gen. Virol. 85 105 117 14718625 1:CAS:528:DC%2BD2cXhtFGrtrk%3D 10.1099/vir.0.19565-0 (Pubitemid 38128875)
- (2004) Journal of General Virology , vol.85 , Issue.1 , pp. 105-117
- Gubser, C.¹ Hue, S.² Kellam, P.³ Smith, G.L.⁴

24
- 73849126308
- 19906926 1:CAS:528:DC%2BC3cXisFylu74%3D 10.1128/JVI.00692-09
- K. Guse M. Sloniecka I. Diaconu, et al. 2010 J. Virol. 84 856 866 19906926 1:CAS:528:DC%2BC3cXisFylu74%3D 10.1128/JVI.00692-09
- (2010) J. Virol. , vol.84 , pp. 856-866
- Guse, K.¹ Sloniecka, M.² Diaconu, I.³

25
- 0033992478
- 10549356 1:CAS:528:DC%2BD3cXltl2ktQ%3D%3D 10.1016/S0065-230X(08)60785-X
- P. Hainaut M. Hollstein 2000 Adv. Cancer. Res. 77 81 137 10549356 1:CAS:528:DC%2BD3cXltl2ktQ%3D%3D 10.1016/S0065-230X(08)60785-X
- (2000) Adv. Cancer. Res. , vol.77 , pp. 81-137
- Hainaut, P.¹ Hollstein, M.²

26
- 3042598758
- Hanson, D. and Diven, D.; Dermatol. Online J.; 2003, vol. 9, no. 2, p. 2.37.
- (2003) Dermatol. Online J. , vol.9 , Issue.2 , pp. 237
- Hanson, D.¹ Diven, D.²

27
- 0032976338
- 10188906 1:STN:280:DyaK1M3gt1Oruw%3D%3D 10.1038/sj.bjc.6690248
- N. Ikeda M. Adachi T. Taki, et al. 1999 Br. J. Cancer 79 1553 1563 10188906 1:STN:280:DyaK1M3gt1Oruw%3D%3D 10.1038/sj.bjc.6690248
- (1999) Br. J. Cancer , vol.79 , pp. 1553-1563
- Ikeda, N.¹ Adachi, M.² Taki, T.³

28
- 16644395449
- 15254730 1:CAS:528:DC%2BD2cXmvF2rur0%3D
- T. Isayeva S. Kumar S. Ponnazhagan 2004 Int. J. Oncol. 25 335 343 15254730 1:CAS:528:DC%2BD2cXmvF2rur0%3D
- (2004) Int. J. Oncol. , vol.25 , pp. 335-343
- Isayeva, T.¹ Kumar, S.² Ponnazhagan, S.³

29
- 0035167322
- Common origin of four diverse families of large eukaryotic DNA viruses
- DOI 10.1128/JVI.75.23.11720-11734.2001
- L. Iyer L. Aravind E. Koonin 2001 J. Virol. 75 23 11720 11734 11689653 1:CAS:528:DC%2BD3MXotlaqs7c%3D 10.1128/JVI.75.23.11720-11734.2001 (Pubitemid 33063263)
- (2001) Journal of Virology , vol.75 , Issue.23 , pp. 11720-11734
- Iyer, L.M.¹ Aravind, L.² Koonin, E.V.³

30
- 33645076499
- 16494962 1:CAS:528:DC%2BD28XivVCmtL4%3D 10.1016/j.virusres.2006.01.009
- L. Iyer S. Balaji E. Koonin L. Aravind 2006 Virus Res. 117 156 184 16494962 1:CAS:528:DC%2BD28XivVCmtL4%3D 10.1016/j.virusres.2006.01.009
- (2006) Virus Res. , vol.117 , pp. 156-184
- Iyer, L.¹ Balaji, S.² Koonin, E.³ Aravind, L.⁴

31
- 84860235947
- US Patent No. 20090317456
- Karrasch, M. and Mescheder, A.; Use of Oncolytic Viruses and Antiangiogenic Agents in the Treatment of Cancer, US Patent No. 20090317456, 2009.
- (2009) Use of Oncolytic Viruses and Antiangiogenic Agents in the Treatment of Cancer
- Karrasch, M.¹ Mescheder, A.²

32
- 0036924160
- Direct evidence that IFN-1β functions as a tumor-suppressor protein
- DOI 10.1089/10799900260442511
- C. Kaynor M. Xin J. Wakefield, et al. 2002 J. Interferon Cytokine Res. 22 1089 1098 12513908 1:CAS:528:DC%2BD3sXkvVCktw%3D%3D 10.1089/10799900260442511 (Pubitemid 36051181)
- (2002) Journal of Interferon and Cytokine Research , vol.22 , Issue.11 , pp. 1089-1098
- Kaynor, C.¹ Xin, M.² Wakefield, J.³ Barsoum, J.⁴ Qin, X.-Q.⁵

33
- 33845993292
- Stem cell collection and gene transfer in fanconi anemia
- DOI 10.1038/sj.mt.6300033, PII 6300033
- E. Kelly S. Russell 2007 Mol. Ther. 15 651 659 17299401 1:CAS:528:DC%2BD2sXhtVejtb7F 10.1038/sj.mt.6300033 (Pubitemid 46043667)
- (2007) Molecular Therapy , vol.15 , Issue.1 , pp. 211-219
- Kelly, P.F.¹ Radtke, S.² Von Kalle, C.³ Balcik, B.⁴ Bohn, K.⁵ Mueller, R.⁶ Schuesler, T.⁷ Haren, M.⁸ Reeves, L.⁹ Cancelas, J.A.¹⁰ Leemhuis, T.¹¹ Harris, R.¹² Auerbach, A.D.¹³ Smith, F.O.¹⁴ Davies, S.M.¹⁵ Williams, D.A.¹⁶

34
- 0027197245
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo
- DOI 10.1038/362841a0
- K. Kim B. Li J. Winer, et al. 1993 Nature 362 841 844 7683111 1:CAS:528:DyaK3sXktVKju7s%3D 10.1038/362841a0 (Pubitemid 23132159)
- (1993) Nature , vol.362 , Issue.6423 , pp. 841-844
- Kim, K.J.¹ Li, B.² Winer, J.³ Armanini, M.⁴ Gillett, N.⁵ Phillips, H.S.⁶ Ferrara, N.⁷

35
- 33746916507
- Systemic Armed Oncolytic and Immunologic Therapy for Cancer with JX-594, a Targeted Poxvirus Expressing GM-CSF
- DOI 10.1016/j.ymthe.2006.05.008, PII S1525001606001833
- J. Kim Y. Oh B. Park, et al. 2006 Mol. Ther. 14 361 370 16905462 1:CAS:528:DC%2BD28XotFylu7c%3D 10.1016/j.ymthe.2006.05.008 (Pubitemid 44184970)
- (2006) Molecular Therapy , vol.14 , Issue.3 , pp. 361-370
- Kim, J.H.¹ Oh, J.Y.² Park, B.H.³ Lee, D.E.⁴ Kim, J.S.⁵ Park, H.E.⁶ Roh, M.S.⁷ Je, J.E.⁸ Yoon, J.H.⁹ Thorne, S.H.¹⁰ Kirn, D.¹¹ Hwang, T.H.¹²

36
- 38049017526
- 1:CAS:528:DC%2BD1cXmvVSlsb0%3D 10.1371/journal.pmed.0040353
- D. Kirn Y. Wang F. Le Boeuf, et al. 2007 PLoS Med. 4 2001 2010 1:CAS:528:DC%2BD1cXmvVSlsb0%3D 10.1371/journal.pmed.0040353
- (2007) PLoS Med. , vol.4 , pp. 2001-2010
- Kirn, D.¹ Wang, Y.² Le Boeuf, F.³

37
- 42049121876
- Enhancing poxvirus oncolytic effects through increased spread and immune evasion
- DOI 10.1158/0008-5472.CAN-07-6515
- D. Kirn Y. Wang W. Liang, et al. 2008 Cancer Res. 68 2071 2075 18381410 1:CAS:528:DC%2BD1cXktVyqtbw%3D 10.1158/0008-5472.CAN-07-6515 (Pubitemid 351521777)
- (2008) Cancer Research , vol.68 , Issue.7 , pp. 2071-2075
- Kirn, D.H.¹ Wang, Y.² Liang, W.³ Contag, C.H.⁴ Thorne, S.H.⁵

38
- 57749201655
- 19104515 1:CAS:528:DC%2BD1MXpt1eh 10.1038/nrc2545
- D. Kirn S. Thorne 2009 Nat. Rev. Cancer 9 64 71 19104515 1:CAS:528:DC%2BD1MXpt1eh 10.1038/nrc2545
- (2009) Nat. Rev. Cancer , vol.9 , pp. 64-71
- Kirn, D.¹ Thorne, S.²

39
- 84860257475
- US Patent No. 2010/0303714A1
- Kirn, D.; Oncolytic Vaccinia Virus Cancer Therapy. US Patent No. 2010/0303714A1, 2010.
- (2010) Oncolytic Vaccinia Virus Cancer Therapy
- Kirn, D.¹

40
- 77953692396
- 20551680 10.1159/000312913
- E. Koonin N. Yutin 2010 Intervirology 53 284 292 20551680 10.1159/000312913
- (2010) Intervirology , vol.53 , pp. 284-292
- Koonin, E.¹ Yutin, N.²

41
- 85056043049
- 20461227 10.2174/1874357901004010001
- H. Lee K. Essani 2010 Open Virol. J. 4 1 6 20461227 10.2174/ 1874357901004010001
- (2010) Open Virol. J. , vol.4 , pp. 1-6
- Lee, H.¹ Essani, K.²

42
- 74549226667
- 19629143 1:CAS:528:DC%2BD1MXovFylsL8%3D 10.1038/cgt.2009.50
- J. Lee M. Hoh Y. Lee, et al. 2010 Cancer Gene Ther. 17 73 79 19629143 1:CAS:528:DC%2BD1MXovFylsL8%3D 10.1038/cgt.2009.50
- (2010) Cancer Gene Ther. , vol.17 , pp. 73-79
- Lee, J.¹ Hoh, M.² Lee, Y.³

43
- 0028233204
- 8012943 1:CAS:528:DyaK2cXkslehsb0%3D
- S. Lee L. Eisenlohr P. McCue, et al. 1994 Cancer Res. 54 3325 3328 8012943 1:CAS:528:DyaK2cXkslehsb0%3D
- (1994) Cancer Res. , vol.54 , pp. 3325-3328
- Lee, S.¹ Eisenlohr, L.² McCue, P.³

44
- 33645095692
- 16503070 1:CAS:528:DC%2BD28XivVCmt7g%3D 10.1016/j.virusres.2006.01.016
- E. Lefkowitz C. Wang C. Upton 2006 Virus Res. 117 105 118 16503070 1:CAS:528:DC%2BD28XivVCmt7g%3D 10.1016/j.virusres.2006.01.016
- (2006) Virus Res. , vol.117 , pp. 105-118
- Lefkowitz, E.¹ Wang, C.² Upton, C.³

45
- 50549091297
- 18628758 1:CAS:528:DC%2BD1cXhtVamt7nP 10.1038/mt.2008.143
- T. Liu T. Hwang B. Park, et al. 2008 Mol. Ther. 16 1637 1642 18628758 1:CAS:528:DC%2BD1cXhtVamt7nP 10.1038/mt.2008.143
- (2008) Mol. Ther. , vol.16 , pp. 1637-1642
- Liu, T.¹ Hwang, T.² Park, B.³

46
- 78649811429
- 1:CAS:528:DC%2BC3cXhsFajs7jM 10.1016/j.micinf.2010.08.012
- J. Liu S. Wennier G. McFadden 2010 Microb. Infect. 12 1144 1152 1:CAS:528:DC%2BC3cXhsFajs7jM 10.1016/j.micinf.2010.08.012
- (2010) Microb. Infect. , vol.12 , pp. 1144-1152
- Liu, J.¹ Wennier, S.² McFadden, G.³

47
- 84860229604
- US Patent No. 2010/0008953A1
- Malarme, D.; Cordier, Y.; and Sene, C.; Process for Producing Poxviruses and Poxvirus Compositions, US Patent No. 2010/0008953A1, 2010.
- (2010) Process for Producing Poxviruses and Poxvirus Compositions
- Malarme, D.¹ Cordier, Y.² Sene, C.³

48
- 0033929022
- 10918490 1:CAS:528:DC%2BD3cXlt1Wrt7k%3D 10.1038/sj.gt.3301237
- A. McCart M. Puhlmann J. Lee, et al. 2000 Gene Ther. 7 1217 1223 10918490 1:CAS:528:DC%2BD3cXlt1Wrt7k%3D 10.1038/sj.gt.3301237
- (2000) Gene Ther. , vol.7 , pp. 1217-1223
- McCart, A.¹ Puhlmann, M.² Lee, J.³

49
- 0035893770
- 11751395 1:CAS:528:DC%2BD38Xht1OntA%3D%3D
- A. McCart J. Ward J. Lee, et al. 2001 Cancer Res. 61 8751 8757 11751395 1:CAS:528:DC%2BD38Xht1OntA%3D%3D
- (2001) Cancer Res. , vol.61 , pp. 8751-8757
- McCart, A.¹ Ward, J.² Lee, J.³

50
- 84860257478
- US Patent No. 7208313
- McCart, A.; Bartlett, D.; and Moss, B.; Combined Growth Factor-Deleted and Thymidine Kinase-Deleted Vaccinia Vinus Vector, US Patent No. 7208313, 2007.
- (2007) Combined Growth Factor-Deleted and Thymidine Kinase-Deleted Vaccinia Vinus Vector
- McCart, A.¹ Bartlett, D.² Moss, B.³

51
- 0346734126
- Extensive gene gain associated with adaptive evolution of poxviruses
- DOI 10.1073/pnas.2136653100
- A. McLysaght P. Baldi B. Gaut 2003 Proc. Natl. Acad. Sci. USA 100 15655 15660 14660798 1:CAS:528:DC%2BD2cXhtVCgsA%3D%3D 10.1073/pnas.2136653100 (Pubitemid 38021045)
- (2003) Proceedings of the National Academy of Sciences of the United States of America , vol.100 , Issue.26 , pp. 15655-15660
- McLysaght, A.¹ Baldi, P.F.² Gaut, B.S.³

52
- 78650537687
- S. Meerani Y. Yao 2010 Eur. J. Sci. Res. 40 156 171
- (2010) Eur. J. Sci. Res. , vol.40 , pp. 156-171
- Meerani, S.¹ Yao, Y.²

53
- 42549153337
- Vaccinia virus uses macropinocytosis and apoptotic mimicry to enter host cells
- DOI 10.1126/science.1155164
- J. Mercer A. Helenius 2008 Science 320 531 535 18436786 1:CAS:528:DC%2BD1cXkvFGkt70%3D 10.1126/science.1155164 (Pubitemid 351590666)
- (2008) Science , vol.320 , Issue.5875 , pp. 531-535
- Mercer, J.¹ Helenius, A.²

54
- 0025967110
- 1988424 1:CAS:528:DyaK3MXpsFyrtQ%3D%3D
- B. Moss B. Ahn B. Amegadzie, et al. 1991 J. Biol. Chem. 266 3 1355 1358 1988424 1:CAS:528:DyaK3MXpsFyrtQ%3D%3D
- (1991) J. Biol. Chem. , vol.266 , Issue.3 , pp. 1355-1358
- Moss, B.¹ Ahn, B.² Amegadzie, B.³

55
- 29144519316
- Poxvirus entry and membrane fusion
- DOI 10.1016/j.virol.2005.09.037, PII S004268220500601X
- B. Mass 2006 Virology 344 48 54 10.1016/j.virol.2005.09.037 (Pubitemid 41814449)
- (2006) Virology , vol.344 , Issue.1 , pp. 48-54
- Moss, B.¹

56
- 84860257482
- 5 ed.; Knipe, D.M. and Howley, P.M.; Eds.; Philadelphia
- Mass, B. and Damon, I.; Poxviridae, in Fields Virology, 5 ed.; Knipe, D.M. and Howley, P.M.; Eds.; Philadelphia, 2007.
- (2007) Poxviridae, in Fields Virology
- Mass, B.¹ Damon, I.²

57
- 84860226450
- US Patent No. 4769330
- Paoletti, E. and Panicali, D.; Modified Vaccinia Virus and Methods for Making and Using the Same, US Patent No. 4769330, 1988.
- (1988) Modified Vaccinia Virus and Methods for Making and Using the Same
- Paoletti, E.¹ Panicali, D.²

58
- 0031924007
- 9610913 1:CAS:528:DyaK1cXjsVWisLk%3D 10.1097/00002371-199805000-00007
- B. Robinson S. Mukherjee A. Davidson, et al. 1998 J. Immunother. 21 211 217 9610913 1:CAS:528:DyaK1cXjsVWisLk%3D 10.1097/00002371-199805000-00007
- (1998) J. Immunother. , vol.21 , pp. 211-217
- Robinson, B.¹ Mukherjee, S.² Davidson, A.³

59
- 0033696418
- 11240708 10.1046/j.1525-1438.2000.010005417.x
- H. Ryu K. Chang S. Chang, et al. 2000 Int. J. Gynecol. Cancer 10 417 424 11240708 10.1046/j.1525-1438.2000.010005417.x
- (2000) Int. J. Gynecol. Cancer , vol.10 , pp. 417-424
- Ryu, H.¹ Chang, K.² Chang, S.³

60
- 0035745574
- Statin-AE: A novel angiostatin-endostatin fusion protein with enhanced antiangiogenic and antitumor activity
- DOI 10.1023/A:1016067717433
- F. Scappaticci A. Contreras R. Smith, et al. 2001 Angiogenes 4 263 268 1:CAS:528:DC%2BD38XkvFCgt74%3D 10.1023/A:1016067717433 (Pubitemid 34832371)
- (2001) Angiogenesis , vol.4 , Issue.4 , pp. 263-268
- Scappaticci, F.A.¹ Contreras, A.² Smith, R.³ Bonhoure, L.⁴ Lum, B.⁵ Cao, Y.⁶ Engleman, E.G.⁷ Nolan, G.P.⁸

61
- 84919960346
- Berlin
- Shchelkunov, S.; Marennikova, S.; and Moyer, R.; Orthopoxviruses Pathogenic for Humans, Berlin, 2005.
- (2005) Orthopoxviruses Pathogenic for Humans
- Shchelkunov, S.¹ Marennikova, S.² Moyer, R.³

62
- 4043113313
- J. Schriewer R. Buller G. Owens 2004 Meth. Mol. Biol. 269 289 308
- (2004) Meth. Mol. Biol. , vol.269 , pp. 289-308
- Schriewer, J.¹ Buller, R.² Owens, G.³

63
- 0030792712
- Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors
- DOI 10.1126/science.277.5327.818
- J. Sheridan S. Marsters R. Pitti, et al. 1997 Science 277 818 9242611 1:CAS:528:DyaK2sXlt1eks78%3D 10.1126/science.277.5327.818 (Pubitemid 27366733)
- (1997) Science , vol.277 , Issue.5327 , pp. 818-821
- Sheridan, J.P.¹ Marsters, S.A.² Pitti, R.M.³ Gurney, A.⁴ Skubatch, M.⁵ Baldwin, D.⁶ Ramakrishnan, L.⁷ Gray, C.L.⁸ Baker, K.⁹ Wood, W.I.¹⁰ Goddard, A.D.¹¹ Godowski, P.¹² Ashkenazi, A.¹³

64
- 78650309660
- 20829890 1:CAS:528:DC%2BC3cXhtFegtr7N 10.1038/cgt.2010.49
- C. Seubert J. Striltzker M. Hess, et al. 2011 Cancer. Gene Ther. 18 42 52 20829890 1:CAS:528:DC%2BC3cXhtFegtr7N 10.1038/cgt.2010.49
- (2011) Cancer. Gene Ther. , vol.18 , pp. 42-52
- Seubert, C.¹ Striltzker, J.² Hess, M.³

65
- 0037282199
- A review of compounds exhibiting anti-orthopoxvirus activity in animal models
- DOI 10.1016/S0166-3542(02)00199-7, PII S0166354202001997
- D. Smee R. Sidwell 2003 Antiviral Res. 57 41 52 12615302 1:CAS:528:DC%2BD3sXhs1Cmsrw%3D 10.1016/S0166-3542(02)00199-7 (Pubitemid 36254720)
- (2003) Antiviral Research , vol.57 , Issue.1-2 , pp. 41-52
- Smee, D.F.¹ Sidwell, R.W.²

66
- 0021082628
- Infectious poxvirus vectors have capacity for at least 25,000 base pairs of foreign DNA
- DOI 10.1016/0378-1119(83)90163-4
- G. Smith B. Moss 1983 Gene 25 21 28 6229451 1:CAS:528: DyaL2cXks1ejuw%3D%3D 10.1016/0378-1119(83)90163-4 (Pubitemid 14241202)
- (1983) Gene , vol.25 , Issue.1 , pp. 21-28
- Smith, G.L.¹ Moss, B.²

67
- 36049009021
- Rational strain selection and engineering creates a broad-spectrum, systemically effective oncolytic poxvirus, JX-963
- DOI 10.1172/JCI32727
- S. Thorne T. Hwang W. O'Gorman, et al. 2007 J. Clin. Invest. 117 3350 3358 17965776 1:CAS:528:DC%2BD2sXht12isrnP 10.1172/JCI32727 (Pubitemid 350096991)
- (2007) Journal of Clinical Investigation , vol.117 , Issue.11 , pp. 3350-3358
- Thorne, S.H.¹ Hwang, T.H.² O'Gorman, W.E.³ Bartlett, D.L.⁴ Sei, S.⁵ Kanji, F.⁶ Brown, C.⁷ Werier, J.⁸ Cho, J.-H.⁹ Lee, D.-E.¹⁰ Wang, Y.¹¹ Bell, J.¹² Kirn, D.H.¹³

68
- 0032620547
- 10527073 1:STN:280:DyaK1MvlsVWqtQ%3D%3D
- T. Timiryasova J. Li B. Chen, et al. 1999 Oncol. Res. 11 133 144 10527073 1:STN:280:DyaK1MvlsVWqtQ%3D%3D
- (1999) Oncol. Res. , vol.11 , pp. 133-144
- Timiryasova, T.¹ Li, J.² Chen, B.³

69
- 70350376151
- 19587709 1:CAS:528:DC%2BD1MXotlSnsb4%3D 10.1038/gt.2009.74
- J. Tysome A. Briat G. Alusi, et al. 2009 Gene Ther. 16 1223 1233 19587709 1:CAS:528:DC%2BD1MXotlSnsb4%3D 10.1038/gt.2009.74
- (2009) Gene Ther. , vol.16 , pp. 1223-1233
- Tysome, J.¹ Briat, A.² Alusi, G.³

70
- 0037444281
- 12649193 1:CAS:528:DC%2BD3sXit1Sgtbg%3D
- L. Wein J. Wu D. Kirn 2003 Cancer Res. 63 1317 1324 12649193 1:CAS:528:DC%2BD3sXit1Sgtbg%3D
- (2003) Cancer Res. , vol.63 , pp. 1317-1324
- Wein, L.¹ Wu, J.² Kirn, D.³

71
- 13344285339
- Identification and characterization of a new member of the TNF family that induces apoptosis
- DOI 10.1016/1074-7613(95)90057-8
- S. Wiley K. Schooley P. Smolak, et al. 1995 Immunity 3 673 682 8777713 1:CAS:528:DyaK28XhtF2iug%3D%3D 10.1016/1074-7613(95)90057-8 (Pubitemid 26091143)
- (1995) Immunity , vol.3 , Issue.6 , pp. 673-682
- Wiley, S.R.¹ Schooley, K.² Smolak, P.J.³ Din, W.S.⁴ Huang, C.-P.⁵ Nicholl, J.K.⁶ Sutherland, G.R.⁷ Smith, T.D.⁸ Rauch, C.⁹ Smith, C.A.¹⁰ Goodwin, R.G.¹¹

72
- 77954670636
- 20543907 1:CAS:528:DC%2BC3cXpvVaqsw%3D%3D 10.3390/v2010078
- H. Wong N. Lemoine Y. Wang 2010 Viruses 2 78 106 20543907 1:CAS:528:DC%2BC3cXpvVaqsw%3D%3D 10.3390/v2010078
- (2010) Viruses , vol.2 , pp. 78-106
- Wong, H.¹ Lemoine, N.² Wang, Y.³

73
- 0036905081
- Development of a replication-selective, oncolytic poxvirus for the treatment of human cancers
- DOI 10.1038/sj.cgt.7700549
- H. Zeh D. Bartlett 2002 Cancer Gene Ther. 9 1001 1012 12522439 1:CAS:528:DC%2BD3sXhs1Ohsw%3D%3D 10.1038/sj.cgt.7700549 (Pubitemid 35462562)
- (2002) Cancer Gene Therapy , vol.9 , Issue.12 , pp. 1001-1012
- Zeh, H.J.¹ Bartlett, D.L.²

74
- 35448962430
- Eradication of solid human breast tumors in nude mice with an intravenously injected light-emitting oncolytic vaccinia virus
- DOI 10.1158/0008-5472.CAN-07-0146
- Q. Zhang Y. Yu E. Wang, et al. 2007 Cancer Res. 67 10038 10046 17942938 1:CAS:528:DC%2BD2sXhtFOnsLvJ 10.1158/0008-5472.CAN-07-0146 (Pubitemid 47621255)
- (2007) Cancer Research , vol.67 , Issue.20 , pp. 10038-10046
- Zhang, Q.¹ Yu, Y.A.² Wang, E.³ Chen, N.⁴ Danner, R.L.⁵ Munson, P.J.⁶ Marincola, F.M.⁷ Szalay, A.A.⁸

75
- 70350068149
- 1:CAS:528:DC%2BD1MXhtlymsLfJ 10.1007/s00438-009-0475-1
- Q. Zhang C. Liang Y. Yu, et al. 2009 Mol. Genet. Genom. 282 417 435 1:CAS:528:DC%2BD1MXhtlymsLfJ 10.1007/s00438-009-0475-1
- (2009) Mol. Genet. Genom. , vol.282 , pp. 417-435
- Zhang, Q.¹ Liang, C.² Yu, Y.³

76
- 77950859546
- 20182517 1:CAS:528:DC%2BC3cXisVehu7w%3D 10.1038/gt.2010.5
- M. Ziauddin Z. Guo M. O'Malley, et al. 2010 Gene Ther. 17 550 559 20182517 1:CAS:528:DC%2BC3cXisVehu7w%3D 10.1038/gt.2010.5
- (2010) Gene Ther. , vol.17 , pp. 550-559
- Ziauddin, M.¹ Guo, Z.² O'Malley, M.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.